19 May 2013
Keywords: sepracor, estorra, effective, long-term, study, results, first
Article | 02 June 2003
The results of the first long-term efficacy and safety study for Sepracor's Estorra (eszopiclone) in patients with insomnia were reported
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 February 2003
17 May 2013
© 2013 thepharmaletter.com